Monalizumab: inhibiting the novel immune checkpoint NKG2A

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Thorbald van Hall, Pascale André, Amir Horowitz, Dan Fu Ruan, Linda Borst, Robert Zerbib, Emilie Narni-Mancinelli, Sjoerd H. van der Burg, Eric Vivier

Journal title: Journal for ImmunoTherapy of Cancer

Journal number: 7/1

Journal publisher: BMJ Publishing Group Ltd & Society for Immunotherapy of Cancer

Published year: 2019

DOI identifier: 10.1186/s40425-019-0761-3

ISSN: 2051-1426